N2N Technologies gets AGM extension to Dec 31, 2026
- N2N Technologies received an extension until December 31, 2026, for its FY26 AGM
- The extension was granted by the Registrar of Companies, Pune
- Change in control occurred via an open offer by Harmony Remedies Private Limited
- Disclosure filed under Regulation 30 of SEBI LODR Regulations, 2015

*this image is generated using AI for illustrative purposes only.
N2N Technologies Limited has secured an extension from the Registrar of Companies (RoC), Pune, to convene its Annual General Meeting (AGM) for the fiscal year ending March 31, 2026 (FY26). The new deadline for the meeting is December 31, 2026.
The regulatory relief comes amid a significant shift in the company's ownership structure. N2N Technologies disclosed that there has been a change in control and management following the conclusion of an open offer by Harmony Remedies Private Limited and its Persons Acting in Concert (PAC).
Regulatory disclosure details
The company filed the disclosure under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was submitted to the Department of Corporate Services at BSE Limited on September 22, 2026.
| Detail | Information |
|---|---|
| Company | N2N Technologies Limited |
| Fiscal Year | FY26 |
| Original Deadline | Standard statutory timeline |
| Extended Deadline | December 31, 2026 |
| Approving Authority | Registrar of Companies, Pune |
Change in control context
The extension request was linked explicitly to the recent corporate action involving Harmony Remedies Private Limited. The acquisition of control through an open offer typically necessitates changes in board composition and operational restructuring, which can delay the preparation of annual accounts and the scheduling of shareholder meetings.
The disclosure was signed by Rahul Dilip Shah, Director of N2N Technologies. No further financial metrics or operational updates were provided in this specific regulatory filing.
What specific strategic initiatives or asset divestitures is Harmony Remedies Private Limited planning to implement following its acquisition of control?
How might the delayed AGM and change in management impact N2N Technologies' credit ratings and ability to secure future debt financing?
Will the new board composition under Harmony Remedies lead to a pivot in N2N Technologies' core business model or sector focus?





























